Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system
Abstract
TAR DNA-binding protein-43 (TDP-43) is a nuclear protein functioning in the regulation of transcription and mRNA splicing. TDP-43 is accumulated in ubiquitinated inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) diseased brains. However, the pathways involved in the clearance of TDP-43 and its pathogenic form (TDP-25), a truncated form of TDP-43, are still not elucidated. In this study, we demonstrated that the protein levels of TDP-43 and TDP-25 were increased in cells treated with a proteasome inhibitor, MG132, or an autophagy inhibitor, 3-MA, whereas, they were decreased in cells treated with an enhancer of autophagy, trehalose. Furthermore, more protein level changes of TDP-25 than TDP-43 were observed in cells treated with above inhibitors or enhancer. Thus, our data suggest that TDP-43 and TDP-25 are degraded by both proteasome and autophagy with TDP-25 being more regulated.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inhibition of MTOR reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS.
“Inhibition of MTOR likewise reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS [353,358,359].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [359]
The citation lists haven’t been fetched yet
References 22 · Cited by 207
- Authors
- Wang, X., Fan, H., Ying, Z., Li, B., Wang, H., & Wang, G.
- Affiliations
- University of Science and Technology of China (CN)
- Corresponding author
- Wang, Xiaoju
- Wang, Hongfeng
- Wang, Guanghui
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 469
- Issue
- 1
- Pages
- 112-116
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W1970745340
- Cited by
- 207
- References
- 22
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 10 · 2021: 10 · 2020: 17 · 2019: 12 · 2018: 16 · 2017: 16 · 2016: 13 · 2015: 15 · 2014: 17 · 2013: 13 · 2012: 14
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Sciences Foundation of China (30770664)
- National High-tech Research and Development program of China 973-projects (2006CB500703)
- Anhui Educational Committee (ZD2008008-2)
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- TDP-43, protein degradation, autophagy, ubiquitin-proteasome system, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, proteasome inhibitors, trehalose, protein clearance
- MeSH terms
- Adenine, Autophagy, Cell Line, DNA-Binding Proteins, Humans, Leupeptins, Pepstatins, Peptide Fragments, Trehalose, Ubiquitin, Proteasome Endopeptidase Complex, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review